In acute kidney injury (AKI), the S3 segment of the proximal tubule is particularly damaged, as it is most vulnerable to ischemia. However, this region is also involved in renal tubular regeneration. To deeply understand the mechanism of the repair process after ischemic injury in AKI, we focused on glial cells missing 1 (Gcm1), which is one of the genes expressed in the S3 segment. Gcm1 is essential for the development of the placenta, and Gcm1 knockout (KO) is embryonically lethal. Thus, the function of Gcm1 in the kidney has not been analyzed yet. We analyzed the function of Gcm1 in the kidney by specifically knocking out Gcm1 in the kidney. We created an ischemia-reperfusion injury (IRI) model to observe the repair process after AKI. We found that Gcm1 expression was transiently increased during the recovery phase of IRI. In Gcm1 conditional KO mice, during the recovery phase of IRI, tubular cell proliferation reduced and transforming growth factor-β1 expression was downregulated resulting in a reduction in fibrosis. In vitro, Gcm1 overexpression promoted cell proliferation and upregulated TGF-β1 expression. These findings indicate that Gcm1 is involved in the mechanisms of fibrosis and cell proliferation after ischemic injury of the kidney.
. The progression of AKI has been shown to increase the risk of developing chronic kidney disease (CKD) 4, 5 and cause deterioration of existing CKD 4, 6 and progression to end-stage renal disease 4, 7, 8 . These changes can increase the number of newly introduced dialysis patients, trigger the development and worsening of cardiovascular diseases, increase the occurrence of complications of metabolic abnormality, and trigger the deterioration of the life prognosis of patients. AKI is known to cause the destruction of renal tubular epithelial cells, and this secondarily causes inflammation and fibrosis of renal parenchyma and rapidly reduces renal function. The injured kidney can recover by proliferation of cells in the proximal tubule [9] [10] [11] , which is the main injured site, and recovery can occur within a few days 3, 12, 13 . However, if the injury is too extensive or does not properly recover owing to insufficient repair of the proximal tubule, the injured kidney may develop chronic fibrotic changes characterized by interstitial enlargement, leukocyte infiltration, and extracellular matrix production. Fibrosis is a general adaptation reaction in the healing process of injured tissue; however, the excessive accumulation of extracellular matrix can destroy normal tissues and cause organ dysfunction, and it is significantly correlated with the extent of renal dysfunction and functional prognosis in CKD [14] [15] [16] [17] . It is important to understand the mechanisms that mediate the progression of AKI to CKD to prevent the development of CKD in patients with AKI.
It is known that ischemia/hypoxia is greatly involved in the progression of AKI to CKD. Rarefaction and loss of capillaries around the renal tubules in AKI cause hypoxia. Hypoxia damages renal tubular epithelial cells, activates inflammatory cells and fibroblasts, and eventually causes progression to CKD . It has been reported that the expression of some genes increases in the S3 segment after ischemic injury, resulting in various changes. For example, Sall1 gene expression makes the kidney vulnerable to ischemia-reperfusion injury (IRI) through a decrease in the expression of heme oxygenase-1 27 , and IRF-1 gene expression promotes inflammation after IRI 28 . Analysis of the genes expressed in the S3 segment is very important to understand the mechanisms of the repair process after ischemic injury and to identify a treatment approach for preventing the progression of AKI to CKD. However, the analysis of other genes expressed in the S3 segment has not yet progressed.
The glial cells missing 1 (Gcm1) gene is one of the genes expressed in the S3 segment 29 , and its function in the kidney is still not entirely known. The Gcm1 protein is a transcription factor involved in development 30 , and in mammals, Gcm1 is mainly expressed in the placenta and kidneys 29 . In the placenta, Gcm1 regulates the expression of the syncytin gene, which promotes the fusion of trophoblasts, is essential for the differentiation of syncytiotrophoblasts, and is a master regulator in complicated labyrinth branching. In previous studies, Gcm1 knockout (KO) mice could not appropriately form the placental labyrinth, and this condition was embryonically lethal 31, 32 . Thus, the function of Gcm1 in organs other than the placenta, such as the kidney, has not been analyzed yet. The present study analyzed the function of Gcm1 in the kidney by specifically knocking out Gcm1 in the kidney. The findings of this study might help better understand fibrosis and cell proliferation after ischemic kidney injury.
Results
Gcm1 expression was markedly increased in the recovery phase of IRI. AKI was replicated in an IRI model, and the blood urea nitrogen (BUN) level was measured as an indicator of renal function. The BUN level was significantly higher in day 1 IRI mice than in day 0 mice, and the level decreased after day 1 (Fig. 1a) . This result is similar to the finding in a previous report 33 . Real-time quantitative RT-PCR (qRT-PCR) was performed to assess the change in Gcm1 expression in the IRI model using kidney samples after IRI. Gcm1 expression was significantly lower in day 1 IRI mice than in day 0 mice (P < 0.01). On the other hand, Gcm1 expression was significantly higher in day 3 IRI mice than in day 1 IRI mice and day 0 mice (both P < 0.01), corresponding to the recovery phase of IRI (Fig. 1b) .
Generation and analysis of Gcm1 conditional KO mice. Gcm1 expression after IRI was markedly increased in the recovery phase of IRI. This result suggests that Gcm1 has some function against kidney damage. We generated conditional KO mice by specifically knocking out Gcm1 in the kidney.
Gcm1, which is a transcriptional regulator, is composed of six exons, and exon 3 primarily codes for a major part of the DNA binding site 34 . We created Gcm1-floxed mice (Gcm1 flox/flox mice) with the exon 3 of Gcm1 flanked by loxP sites to knock out exon 3 in the Cre-LoxP system (Fig. 2a) . Since Wt1 is expressed in the metanephric mesenchyme during embryonic kidney development 35 , Gcm1 flox/flox mice were crossed with Wt1 GFPCre/+ mice to create Wt1
GFPCre/+ ; Gcm1 flox/flox mice which conditionally knock out Gcm1 in renal tubules. These mice were crossed with Gcm1 flox/flox mice to obtain Gcm1 flox/flox control mice and Wt1 GFPCre/+ ; Gcm1 flox/flox KO (cKO) mice. Genomic PCR was performed to check whether Gcm1 was properly knocked out in the kidney. In control mice, a band measuring 1053 bp was observed, and in cKO mice, the region between loxP sites was lost and a band measuring 170 bp was observed (Fig. 2b) . Additionally, the finding was confirmed with RT-PCR using cDNA prepared from the kidney. In control mice, a band measuring 503 bp was observed, and in cKO mice, exon 3 disappeared and no band was observed (Fig. 2c) . These results confirmed that Gcm1 was completely knocked out in the kidney. We assessed Gcm1 expression in the kidneys of mice using in situ hybridization. In control mice, Gcm1 expression was noted in the cortex region, and the strongest staining was observed at the corticomedullary junction where the S3 segment exists 29 ( Fig. S1 ). On the other hand, in cKO mice, no expression was observed. Thus, it was confirmed that in cKO mice, Gcm1 was knocked out in the entire cortex region and corticomedullary junction where it is usually expressed. Gcm1 expression shows a marked increase in the recovery phase of ischemia-reperfusion injury (IRI). (a) Blood urea nitrogen (BUN) level is measured as an indicator of renal function in wild-type mice before IRI (day 0) or after IRI (ischemia followed by 1, 2, 3, 4, 5, and 14 days of reperfusion). (b) Gcm1 expression in the kidney is examined using real-time polymerase chain reaction in wild-type mice before IRI (day 0) or after to IRI (ischemia followed by 1, 2, 3, 4, 5, and 14 days of reperfusion). Data are presented as mean ± SEM (n = 9). *P < 0.01.
www.nature.com/scientificreports www.nature.com/scientificreports/ To assess whether the morphology of the cKO kidney differs from the usual morphology, we observed the morphology of the E18.5 cKO kidney. On hematoxylin and eosin (HE) staining, we found that the structures of the glomeruli and renal tubules of the cortex and medulla were maintained in the cKO kidney and no obvious embryological phenotype was observed (Fig. S2) . Similarly, in adult mice aged 6-8 weeks, the kidneys were harvested and kidney morphology was assessed in detail. On HE staining and assessment of various renal tubule markers, no obvious differences were observed between control and cKO mice (Figs S3 and S4). Additionally, on blood biochemistry assessments and urinalysis, no differences were observed between control and cKO mice (Supplementary Table S1 ). These results suggest that in the steady state, cKO does not affect the morphology and function of the kidney.
Fibrosis after IRI was mild in Gcm1 cKO mice. As mRNA levels of Gcm1, which is expressed in the cortex region and corticomedullary junction, changed after IRI, function analysis of Gcm1 after IRI was performed using cKO mice. First, through biochemical assessment of blood, we examined whether the degree of renal dysfunction caused by IRI differed between control and cKO mice. In both groups of mice, the peak BUN level was noted on day 1 after IRI, and no significant differences in renal dysfunction were observed on biochemical assessment (Fig. 3a) . Next, we evaluated the morphological differences between control and cKO mice after IRI by periodic acid-Schiff (PAS) staining (Fig. 3b) . The tubular injury score after IRI, which was evaluated by PAS staining to quantify the differences in injury between control and cKO mice, did not differ between the two (Fig. 3c) . It has been reported that HIF-1α is activated for organ protection against hypoxia and ischemic injury 36 . However, the stable expression of HIF-1α leads to the progression of fibrosis, causing organ damage 37 . We evaluated whether there was a difference in HIF-1α expression after IRI between control and cKO mice. HIF-1α expression showed a similar trend after IRI in control and cKO mice (Fig. 3d) , indicating that the degree of ischemic injury was not different between control and cKO mice.
We also assessed the degree of fibrosis after IRI with Masson's trichrome staining (Fig. 3e) and Sirius red staining (Fig. S5a) . After the recovery phase of IRI (days 5 and 14), Masson's trichrome staining showed that the fibrosis area (staining region of collagen fibers) was smaller in cKO mice than in control mice (Fig. 3f) . Additionally, on Sirius red staining, the fibrosis area (ratio of the Sirius red-positive area [collagen I (ColI), III]) was significantly smaller in cKO mice than in control mice (Fig. S5b) , similar to the finding with Masson's trichrome staining (Fig. 3f) . These results suggested that the degree of fibrosis was lower in cKO mice than in control mice.
Expression of fibrosis-related genes after IRI decreased in Gcm1 cKO mice. The mechanism of fibrosis in the kidney involves the activation and proliferation of fibroblasts (myofibroblasts), resulting in excessive extracellular matrix production 21 . Therefore, we evaluated the expression of myofibroblast, fibroblast, extracellular matrix, and fibrosis marker genes using real-time qRT-PCR and immunostaining. After the recovery phase of IRI (days 5 and 14) , the expressions of the myofibroblast marker alpha-smooth muscle actin (α-SMA) (Fig. 4a) , fibroblast marker vimentin (Fig. 4b) , extracellular matrix marker fibronectin (Fig. 4c) and fibrosis markers MMP-7 (Fig. 4d) , and ColI (Fig. 4e) were significantly lower in cKO mice than in control mice. Additionally, on immunostaining, α-SMA, vimentin, and fibronectin expressions were significantly lower in cKO mice than in control mice (Fig. 5a,b) . These results indicated that fibrosis was lower in cKO mice than in control mice. . On day 3 after IRI, Gcm1 expression increased. We determined whether the cell proliferative capacity differs between control and cKO mice with Ki67 staining. In control mice, the number of Ki67-positive cells increased after IRI. However, in cKO mice, the number of Ki67-positive cells clearly decreased (Fig. 6a) , and it was suggested that cell proliferation was especially decreased in the recovery phase of IRI. To investigate the cause for this difference, we assessed cell death in the corticomedullary junction of the kidney after IRI in control and cKO mice. The numbers of TUNEL-positive cells in both control and cKO mice were counted, and there were no significant differences in the numbers on days 1 and 3 after IRI. In both groups of mice, the number of TUNEL-positive cells was the highest on day 1 when renal function was the most reduced, and the number of TUNEL-positive cells on day 3 tended to decrease to about one-third the number on day 1 (Fig. S6a,b) . These results suggested that the degree of cell death owing to IRI was not different between control and cKO mice and that there was a difference only in cell proliferation. To analyze cell proliferation after IRI in more detail, we assessed the number of cells in which 5-ethynyl-2′-deoxyuridine (EdU) was incorporated on days 1 and 3 after IRI (when cell proliferation occurred). EdU was injected intraperitoneally 25 and 73 h after IRI, and 8 h after each injection of EdU, the kidneys were harvested and observed (Fig. 6b) . The number of EdU-positive cells in cKO mice was about half the number in control mice on day 1, and the cell proliferative capacity in cKO mice decreased on day 1 after IRI. Similarly, the number of EdU-positive cells in cKO mice was about one-third the number in control mice on day 3, and the cell proliferative capacity in cKO mice decreased even on day 3 after IRI ( Fig. 6c,d ). In addition, we analyzed whether the proliferating cells were tubular or interstitial cells on day 3, which is the point when cell proliferation is considered the most increased after IRI 39, 40 . When the number of EdU-positive cells was evaluated by dividing To confirm whether the proliferating cells in the interstitium after IRI are myofibroblasts, α-SMA immunostaining and EdU staining were performed on day 3 after IRI ( Fig. 6f ). There were many α-SMA and EdU double-positive cells in control mice (Fig. 6f) . The number of double-positive cells was significantly lower in cKO mice than in control mice (Fig. 6g) . These results indicated that myofibroblast proliferation in cKO mice was reduced.
Transforming growth factor-β1 (TGF-β1) induces fibroblast proliferation and activation after IRI 22 ; thus, we evaluated TGF-β1 expression (Fig. 6h) . In control mice on day 3 after IRI (remarkable difference was noted in Gcm1 expression [ Fig. 1b]) , TGF-β1 expression increased (Fig. 6h) . However, in cKO mice, no significant increase in TGF-β1 expression was noted (Fig. 6h) . This result suggested that Gcm1 in the kidney promoted tubular and interstitial cell proliferation after IRI. With a focus on the interstitium, it was shown that Gcm1 was related to the regulation of myofibroblast proliferation associated with fibrosis after ischemic injury, and it was suggested that a reduction in cell proliferation is associated with less fibrosis after IRI.
Gcm1 and TGF-β1 are co-expressed in the proximal renal tubule at the corticomedullary junction after ischemia-reperfusion injury. To elucidate the role of Gcm1 in kidney injury and repair associated with IRI, it is important to know the precise localization of Gcm1 after IRI. Normally, TGF-β1 expression increases after IRI, but it was found to decrease in cKO mice (Fig. 6h) . This result suggests that Gcm1 is involved in the expression of TGF-β1 after IRI. To investigate whether Gcm1 is directly or indirectly involved in the expression of TGF-β1, it is necessary to know the details of cells expressing Gcm1 and TGF-β1. We confirmed their expression by in situ hybridization, but we could not confirm the expression of TGF-β1. Therefore, we used ultrasensitive RNA in situ hybridization with RNAscope. We had examined day 0 kidney and 3 days after IRI kidney, which indicated the highest expression of Gcm1 after IRI, in control and compared with cKO mice kidney. In control mice, expression of Gcm1 was found in the renal tubules, especially in the corticomedullary junction (Fig. 7a, a′ and S8 ). Gcm1 expression was increased after IRI (Fig. 7b, b′ and b″) . TGF-β1 expression was scarcely observed in day 0 kidney (Fig. 7a, a′) but was remarkably observed after IRI, and many cells co-localized with Gcm1 were observed in the corticomedullary junction (Fig. 7 b″) . TGF-β1 expressing cells not co-localized with Gcm1 also existed. In cKO mice, Gcm1 expression was not observed in either day 0 or after IRI kidneys (Fig. 7c , c′, d, d′ and d″), and TGF-β1 expression was decreased more in cKO mice than in control mice (Fig. 7d, d′ and d″) .
Gcm1 increases α-SMA expression by upregulating TGF-β1 expression in vitro. After IRI, Gcm1
and TGF-β1 were expressed in the same cells of the proximal renal tubules at the corticomedullary junction, Figure 4 . Knockout of Gcm1 decreases the mRNA expression of various fibrosis-related genes after ischemiareperfusion injury (IRI). (a-e) Expression of fibrosis-related genes in the kidneys from control and Gcm1 conditional knockout (cKO) mice before IRI (day 0) or after IRI (ischemia followed by 1, 3, 5, and 14 days of reperfusion). α-SMA (a), vimentin (b), fibronectin (c), MMP-7 (d), and collagen I (col I) (e) are assessed. Data are presented as mean ± SEM (n = 6). *P < 0.05 vs. control; **P < 0.01 vs. control.
www.nature.com/scientificreports www.nature.com/scientificreports/ suggesting the association between Gcm1 and TGF-β1. In vitro experiments were then conducted to investigate whether the transient increase in expression of Gcm1 after IRI directly increases TGF-β1 expression. TGF-β1 acts as a common inducer of α-SMA expression and collagen and fibronectin synthesis in fibroblasts. TGF-β1 plays an important role in myofibroblast differentiation during wound healing and fibrocontractive diseases by regulating the expression of α-SMA in myofibroblasts 41, 42 . To also investigate the effect of Gcm1 overexpression on α-SMA leading to fibrogenesis, we evaluated the expression of TGF-β1 and α-SMA using real-time qRT-PCR in cells transfected with empty vector plasmid DNA (control) and vector plasmid DNA containing the Gcm1 gene. We found that the expression of TGF-β1 and α-SMA was higher in the group overexpressing the Gcm1 gene than in the control group (Fig. 7e) . Next, to confirm whether Gcm1 increases the expression of α-SMA via TGF-β1, we conducted an experiment treating cells overexpressing Gcm1 with a TGFβR1-specific inhibitor (LY-364947) that inhibits TGF-β signaling pathways. We evaluated the expression of TGF-β1 and α-SMA using real-time qRT-PCR in the group overexpressing Gcm1 and the group overexpressing Gcm1 treated with LY-364947. In cultured cells supplemented with LY-364947, the expression of TGF-β1 was similar to that in untreated cultures, but the expression of α-SMA was suppressed (Fig. 7f) . These results indicate that Gcm1 promotes the expression of TGF-β1, thereby increasing the expression of α-SMA.
Analysis of Gcm1-related genes after acute kidney injury following IRI. To further investigate
whether there is a Gcm1-related gene other than TGF-β1 which directly leads to fibrosis, we evaluated the expression of genes, such as the Wnt family and FZD5, which are associated with Gcm1 as reported in a placenta study 43, 44 . In the kidney, sustained activation of Wnt signaling reportedly drives the progression of AKI to CKD 45 . However, among these genes, there was no clear change in Gcm1 cKO mice after IRI in the kidney (Figs. S9a,b) . Therefore, other than TGF-β1, we could not find any Gcm1-related gene leading to fibrosis. www.nature.com/scientificreports www.nature.com/scientificreports/
Discussion
Our findings indicated that Gcm1 expression changes during ischemic injury and that Gcm1 is involved in fibrosis and cell proliferation after kidney tissue injury.
Gcm1 complete KO is embryonically lethal at E10.5 32 , because Gcm1 is essential for placental formation. Thus, in previous studies, the function of Gcm1 was unknown in organs, except for the placenta. We analyzed its function in the kidney using cKO mice (Gcm1 was knocked out in the kidney). In the kidney, Gcm1 is known to be expressed in the S3 segment; however, our analysis revealed that it is widely expressed in the renal tubules at the cortex region and corticomedullary junction. We knocked out Gcm1 in the entire nephron, which is derived from the metanephric mesenchyme, by crossing Wt1
GFPCre/+ mice with Gcm1-floxed mice. This approach made it possible to completely knock out Gcm1 in the kidney. Interestingly, Gcm1 is also expressed in the developing kidney 29 ; however, we could not identify any difference between control and cKO mice. In addition, even after birth, there were no differences in electrolytes on blood biochemical tests and urine biochemical tests between control and cKO mice. These results indicate that Gcm1 expressed in the renal tubules is not an essential gene for kidney differentiation and development and does not have a biochemical effect in the steady state.
We evaluated renal function by assessing the BUN level and the results showed that renal function did not differ between control and cKO mice in the recovery phase of IRI. However, changes in cell proliferation and fibrosis were observed between control and cKO mice kidney after IRI. With regard to fibrosis, it has already been reported that the production of extracellular matrix begins to rise around 3 days after IRI 46 , and we found that Data are presented as mean ± SEM for five mice in each group. **P < 0.01 control vs. cKO. (h) TGF-β1 expression assessed using real-time polymerase chain reaction in the kidneys of control and cKO mice before IRI (day 0) or after IRI (ischemia followed by 1, 3, 5, and 14 days of reperfusion). *P < 0.05; **P < 0.01, n > 4 at each time point.
the expression of Gcm1 transiently increased at the same time. In addition, it was shown that the expression of fibrosis-related genes decreased when Gcm1 was knocked out. These findings suggest that Gcm1 has a function related to fibrosis after IRI. Furthermore, some reports have shown that the expression of several genes in the S3 segment increases after IRI, and these genes are involved in kidney fibrosis formation via various mechanisms associated with angiogenesis and the inflammatory response 27, 28 . There are several molecules related to fibrosis, and we need to investigate the relationship between them and Gcm1 in the future.
Normally, with severe ischemia injury, cell death (renal tubule necrosis and apoptosis) occurs, and viable tubular cells undergo cell division and replace the lost cells 47 . It has been shown that the replacement cells ultimately form normal epithelial cells 48 . Some reports have mentioned that peak cell proliferative capacity is noted 3-4 days after IRI 39, 40 . Consistent with the results of previous reports, our results indicate that cell proliferation in control mice increased on day 3 rather than on day 1 after IRI. However, in cKO mice, increasing cell proliferative capacity could not be confirmed on day 3 after IRI. Thus, compared with control mice, the usual cell proliferation response to IRI did not occur in cKO mice. Previous studies have reported that when the proliferative capacity of renal tubular cells decreases after IRI, kidney repair remains incomplete and adequate recovery of renal function does not occur [49] [50] [51] . However, there was no difference between cKO and control mice in the degree of kidney injury, even though there was a difference in cell proliferation. In the cell proliferation experiments, a small number of proliferating cells was observed in cKO mice, and the cells were probably involved in kidney regeneration. Analysis of long-term observations after IRI will evaluate whether there is more difference in kidney regeneration between control and cKO mice. Gcm1 gene is one of the mammalian homologs of the Gcm gene essential for glial cell development in Drosophila and Gcm2, other Gcm family, is essential for parathyroid development 52 . There www.nature.com/scientificreports www.nature.com/scientificreports/ are several reports on the relationship between Gcm and cell proliferation. In Drosophila, Gcm overexpression was found to promote glial cell proliferation 53 , and knockout of Gcm2 expression in mice was found to be lead to reduce parathyroid cell proliferation 54 . Therefore, the Gcm1 gene may also be involved in cell proliferation. In our study, Gcm1 overexpression was found to promote cell proliferation in vitro (Fig. S7) , and Gcm1 knockout was found to inhibit cell proliferation after ischemic kidney injury in vivo (Fig. 6c,d ). These results suggest that Gcm1 might be involved in cell proliferation.
Further, what is affected by the reduced cell proliferation by Gcm1 KO in mice kidney? Another remarkable difference between control and cKO mice after IRI is a decrease in fibrosis. Tissue fibrosis, revealed by histology and qRT-PCR, was much more prominent in control mice than in cKO mice. In general, injured tubules are associated with cell proliferation, and at injury, growth factors are produced from renal tubular epithelial cells and proliferation of fibroblasts occurs 42 . Previous reports have mentioned that the main growth factor is TGF-β1, which reportedly activates myofibroblasts and promotes fibrosis after IRI 22, 55, 56 . A previous study involving IRI also reported that the number of α-SMA and EdU double-positive cells decreased and fibrosis reduced through interference of the production of fibroblast growth factor by renal tubules 21 . Our results indicate that in cKO mice after IRI, there was a clear decrease in fibroblast proliferative capacity in the interstitium, and the expression of TGF-β1 decreased. These results suggest that the factors associated with the proliferation of fibroblasts may be downstream of Gcm1. Furthermore, by ultrasensitive RNA in situ hybridization, we found that Gcm1-expressing cells also expressed TGF-β1 and we showed by in vitro experiments that Gcm1 increased α-SMA via TGF-β1. Our results may demonstrate an association between Gcm1 and TGF-β1 in kidney fibrosis. Since expression of TGF-β1 is observed even in cKO mice (Fig. 7c,d) , TGF-β1 can be induced by IRI even in the absence of Gcm1. However, fibrosis in cKO mice was considered to be mild, since the expression of TGF-β1 was significantly decreased as compared with control mice. A previous study reported that the cell proliferative capacity of tubular and interstitial cells decreased and fibrosis was mild after knocking out a gene related to the cell cycle or growth factor in mice and that the change in cell proliferation was related to fibrosis 57, 58 . Our findings suggest that KO of Gcm1 reduces the cell proliferative capacity of renal tubular cells, then decreases the expression of factors related to the proliferation of fibroblasts produced from renal tubular cells, decreases the interstitial cell proliferation capacity, and indirectly makes fibrosis mild. Moreover, KO of Gcm1 did not affect kidney tissue damage evaluated by tubular injury score. These results suggest that KO of Gcm1 is involved in fibrosis rather than in repair of tissue after AKI. Therefore, we speculate that there might be two independent functional cells associated with repair and fibrosis occurring after IRI. Gcm1 is involved in cell proliferation associated with this fibrosis, and it may not be directly involved in the proliferation of cells for repair. However, since renal dysfunction due to fibrosis is not reflected early in serologic renal function, it is presumed that the recovery of renal function, as assessed by BUN level, did not significantly differ between control and cKO mice in the present study. In the future, detailed analysis of the fibrosis caused to various degrees of kidney damage is desired.
In addition, in this study, we showed that Gcm1 expression transiently decreased immediately on days 1 and 2 after IRI, and the expression sharply increased on day 3 after IRI, which is the recovery phase of renal function. However, we could not clarify the reason for the change. Some studies have shown that Gcm1 is associated with ischemia 59, 60 , and it is presumed that even in the kidney, Gcm1 expression can increase in response to hypoxia by the change in HIF-1α after IRI, as shown in the study (Fig. 3d) .
To investigate the possibility that the function of GCM1 in mouse is similar to that in the human kidney, we used human transcriptome data from a previous report 61 and found that GCM1 expression was observed in the renal tubules (data not shown). In addition, we overexpressed Gcm1 in HEK 293, which is a human cell and found increased expression of TGF-β1 and α-SMA. This suggested the possibility that the Gcm1-related function associated with fibrosis in mouse kidney exists in human kidney. Therefore, it may be possible to approach new drug discoveries related to the treatment of fibrosis after AKI by regulation of Gcm1.
We acknowledge that there are several limitations in this study. First, currently, we only found TGF-β1 as a factor related to Gcm1, which causes myofibroblast proliferation in the interstitium. Among the genes that were reported to be associated with Gcm1 in a placenta study 43, 44 , no clear change was observed in Gcm1 cKO mice after IRI in the kidney (Fig. S9a,b) . Second, we could not clarify why Gcm1 transiently changes its expression after IRI. Despite these limitations, this study is valid because the function of Gcm1 in the kidneys was confirmed for the first time. To prevent the progression of AKI to CKD, it may be necessary to analyze the detailed mechanisms of crosstalk among renal tubular and interstitial cells after ischemic injury through Gcm1 in the future.
In conclusion, Gcm1 is involved in the mechanisms of fibrosis and cell proliferation after ischemic injury of the kidney. Further analyses on Gcm1 in kidney injury are expected to enhance our existing knowledge on improving fibrosis occurring in CKD.
Methods
Animals. Mice aged 6-8 weeks were used for experiments. For wild-type mice analyses, male C57BL/6 J mice were purchased from Japan Charles River Laboratories (Kanagawa, Japan). The wild-type mice were used for BUN assay and quantitative analysis of Gcm1 to confirm normal reactivity under the condition of IRI. Homozygous Gcm1-floxed mice (Gcm1 flox/flox ) (C57BL/6 N background) were generated as follows. The BAC clone RP23-463G12 for the target region was obtained from Open Biosystems (Huntsville, AL, USA). LoxP and a FRT-flanked neomycin-resistance gene cassette (FRT-PGK-gb2-neo-FRT) (Gene Bridges, Heidelberg, Germany) were inserted using a BAC Subcloning Kit with Red/ET Recombination (Gene Bridges). Exon 3 of Gcm1 was flanked by loxP sites (Fig. 2a) . The first loxP was inserted into intron 2 (346 bp upstream of exon 3). The FRT-flanked neo cassette and second loxP were inserted into intron 3 (1827 bp downstream of exon 3). The targeting vector was constructed by subcloning the loxP-flanked exon 3 region of Gcm1 with homologous arms into the DT-A-pA vector (Riken BRC, Tsukuba, Japan). Gcm1-floxed mice were generated and provided by Riken BRC through the National Bio-Resource Project of MEXT, Japan. The mouse chimeras were mated with (2019) 9:7883 | https://doi.org/10.1038/s41598-019-44161-y www.nature.com/scientificreports www.nature.com/scientificreports/ C57BL/6 N female mice, and F1 Gcm1 flox/+ mice were genotyped using genomic PCR (Gcm1-floxed mice genotyping, 5′-GGCATAGATAGCACACACCTTGTCG-3′ and 5′-TGAAAGGGTCTTTTGTCCCCTAAAGG-3′; 75 and 109 bp bands were generated for the wild-type and floxed alleles). Homozygous mice were maintained with brother-sister mating over 20 generations. Mutant mice were mated with FLP mice to remove the neomycin-resistance gene in Gcm1 flox/flox mice. Wt1EGFPCre/+ knock-in mice (Wt1tm1[EGFP/cre] Wtp/J, stock no: #010911) were purchased from Jackson Laboratory (Bar Harbor, ME, USA). By mating Gcm1-floxed mice with Wt1EGFPCre/+ heterozygous mice (Wt1 GFPCre/+ ), cKO mice, in which the Gcm1 gene was specifically disrupted in the metanephric mesenchyme (genotype: Wt1
GFPCre/+ ; Gcm1 flox/flox ), were created. These mice were crossbred with homozygous Gcm1-floxed mice (genotype: Gcm1 flox/flox ) to generate 50% Wt1
GFPCre/+ ; Gcm1 flox/flox mice (cKO mice) and 50% Gcm1 flox/flox mice (control mice) within the same litter. A routine PCR protocol was adopted for genotyping tail DNA samples using KOD Fx (Toyobo, Osaka, Japan) with the following primer pairs: Wt1
GFPCre/+ mice genotyping, 5′-TCCCGCTTGTCACAACTGAC-3′, 5′-CCCTGTCCGCTACTTTCAGA-3′, and 5′-GAACTTCAGGGTCAGCTTGC-3′, which generated 1578 and 1131 bp fragments for wild-type mice and a 1131 bp fragment for Wt1
GFPCre/+ mice. Genomic PCR and RT-PCR were performed to confirm whether Gcm1 was properly knocked out in the kidney (Fig. 2b,c) . We used primer 1 F (5′-GGCATAGATAGCACACACCTTGTCG-3′) and primer 1 R (5′-CCATGAGCCAATCTCTTTCC-3′) for genomic PCR and primer 2 F (5′-ACGTGAAAACGACTGACTGGT-3′) and primer 2 R (5′-AGGAAGCGCCTTCGCTG-3′) for RT-PCR. For genotyping, we used a 1 Kb Plus DNA Ladder (Invitrogen) and simultaneously ran the samples of control and cKO mice. Control mice and cKO mice were used in all experiments.
All animal experiments were approved by the Animal Care and Experimentation Committee of the Jikei University School of Medicine (No. 2015-096C1) and were performed in accordance with approved guidelines.
Renal IRI model. Mice were anesthetized with isoflurane (2% for induction and 1.5% for maintenance), and a back incision was made. Both renal arteries were clamped for 30 min. After clamp removal, the kidneys were inspected for recovery of blood flow and signs of internal bleeding, and the incision was closed. Sham-operated mice underwent the same procedures but without occlusion of the renal pedicle. The intrarectal temperature was maintained at 36.5-37.5 °C with a heating pad. Mice were euthanized before IRI (day 0), after the sham operation and after IRI. Blood and kidneys were collected and fixed in 4% PFA at 4 °C overnight for various analyses.
BUN assay. The extent of kidney damage was assessed by analyzing BUN at different time points simultaneously. For analyzing renal function, blood samples were collected from the heart under anesthesia before IRI (day 0) and after IRI. The BUN level was determined using SPOTCHEM (ARKRAY, Kyoto, Japan), according to the protocols specified by the manufacturer. Real-time PCR. Quantitative analyses of the genes for α-SMA, vimentin, fibronectin, ColI, MMP7, TGF-β1, HIF-1α, Gcm1, and GAPDH were performed using real-time PCR (Rotor-Gene Q/RG-6000; Qiagen, Hilden, Germany). Total RNA was extracted from harvested kidney tissue using the TRIzol RNA isolation system (NucleoSpin ® RNA, TaKaRa Bio, Shiga, Japan). First-strand cDNA was synthesized from 1 μg of RNA using a reverse transcriptase kit (High-Capacity RNA-to-cDNA ™ Kit, Thermo Fisher Scientific, Waltham, MA, USA).
Real-time PCR was performed using the Roter-Gene SYBR Green PCR Kit (Qiagen). The PCR reaction involved 40 cycles, and the conditions were as follows: 95 °C for 5 s and 60 °C for 10 s. The specific primer sequences used are mentioned in Supplementary Table S2 . Primers for Wnt family were previously described 45 . Expression of the various genes was calculated after normalization with GAPDH.
In situ hybridization. Fixed specimens were rinsed several times with cold phosphate-buffered saline (PBS), immersed in 30% sucrose (prepared with PBS) at 4 °C, embedded in Tissue Tek OCT compound (4583D; Sakura, Tokyo, Japan), and frozen. The specimens were then sectioned at a thickness of 10 μm using a cryostat (CM3050S; Leica, Tokyo, Japan). Digoxigenin-labeled antisense RNA probes were synthesized using the DIG RNA Labeling Kit (SP6/T7, Roche Diagnostics, Risch-Rotkreuz, Switzerland) with plasmids containing the Gcm1, NaPiIIa, Napsa, and NKCC2 genes. In situ hybridization was performed as previously described 62 with some modifications.
Renal histological analysis. Fixed specimens were paraffin-embedded and sectioned at a thickness of 4 µm, according to the standard procedure. The sections were deparaffinized and rehydrated. Tissues were stained with HE, PAS, Masson's trichrome, and Picrosirius red (Cosmo Bio Company, Ltd., Tokyo, Japan). They were also subjected to immunofluorescence staining, proliferation assay, and TUNEL assay. For the histological analysis of tubulointerstitial injury (tubular necrosis or damage, loss of brush border, tubular dilatation, tubular atrophy, and tubular casts in the sample) after IRI, the sections were stained with PAS. Ten corticomedullary fields were examined in each section at 200× magnification, and a semiquantitative analysis of tubulointerstitial injury was performed. Tubular injury was scored as follows on PAS by estimating the percentage of tubules that showed epithelial necrosis, loss of brush border, or had necrotic debris or cast 63 : 0, none; 1, ≤10%; 2, 11%-25%; 3, 26%-45%; 4, 46%-75%; and 5, >76%. Fibrosis was assessed in similar tissue sections stained with Masson's trichrome and Sirius red 64 , and 10 fields were randomly selected from each kidney. Masson's trichrome staining (standard diagnostic protocol) was performed on days 5 and 14 after IRI to estimate tubulointerstitial lesions. For investigating interstitial collagen deposition, paraffin sections were stained with Sirius red. For quantification, regions of interest were defined, and large vessels and glomeruli were excluded from the analysis. The proportion of the Sirius www.nature.com/scientificreports www.nature.com/scientificreports/ red-positive area was analyzed automatically using Image J software (National Institutes of Health, Bethesda, MD, USA) as a percentage of the area of interest.
Immunofluorescence staining. Paraffin sections at a thickness of 4 µm were used for immunofluorescence staining. The primary antibodies were against α-SMA (ab5694; Abcam, Cambridge, UK), vimentin (D21H3, #5741, Cell Signaling, Beverly, MA, USA) and fibronectin (F3647, Sigma-Aldrich, St. Louis, MO, USA). The secondary antibodies were Alexa Fluor ® 488-conjugated antibodies (Jackson Immuno-Research Laboratories, West Grove, PA, USA). For nuclei staining, 4,6-diamidino-2-phenylindole (DAPI) was used. All sections were visualized under a confocal microscope (LSM880, Carl Zeiss, Oberkochen, Germany). The interstitial areas of α-SMA, vimentin, and fibronectin on immunostaining were quantified in 10 regions of randomly selected fields using Image J software, and the results were expressed as a percentage of the cortical area stained (large blood vessels were excluded from the analysis for α-SMA staining).
In vivo proliferation assay. Ki67 immunostaining was performed on paraffin-embedded sections treated with HistoVT One (Nacalai Tesque, Kyoto, Japan) at 105 °C for 15 min for antigen retrieval. According to the manufacturer's instructions, tissue sections were incubated with anti-Ki67 primary antibodies (RM-9106; LabVision, Fremont, CA, USA) overnight at 4 °C. Bound primary antibodies were detected using biotinylated goat anti-rabbit IgG antibodies (Vector Laboratories, Burlingame, CA, USA) and the Vectastain Elite ABC standard kit (Vector Laboratories). Tissue sections were stained using DAB-H 2 O 2 as a substrate.
To directly measure DNA synthesis, the EdU assay was performed. Plasmid constructs for cell culture assays. Generation of the pCAGGS plasmid containing the Flagtagged Gcm1 (pCAGGS-Gcm1-Flag), mouse coding sequence of Gcm1 was amplified by PCR from mouse kidney cDNA using the primers: forward, 5′-CATGCCATGGAACTGGACGACTTTGAT-3′ and reverse, 5′-TCTTAAAGAACAGAAGTTTAGGAGCA-3′ to generate an NcoI restriction site in the 5′end. Next, Flag-tagged added to Gcm1 PCR product was performed with the following primers: forward,5′-CATG CCATGGAACTGGACGACTTTGAT-3′ and reverse, 5′-GGAATTCTTACTTGTCATCGTCATCCTTG TAGTCGATGTCATGATCTTTATAATCACCGTCATGGTCTTTGTAGTCTCTTAAAGAACAGAAGT-3′, to generate a Flag fragment containing an EcoI restriction site in the 3′end. This fragment was inserted between the NcoI and EcoI restriction sites to generate the pSlax21-Gcm1-Flag vector. Subsequently, Gcm1-flag sequences were excised from the pSlax21 vector by ClaI restriction enzyme and inserted into the ClaI site of the pCAGGS plasmid to generate pCAGGS-Gcm1-Flag. The expression of pCAGGS-Gcm1-Flag was verified using Flag-antibody (Fig. S10) .
Cell culture assays. HEK293 was cultured in high-glucose Dulbecco's modified Eagle medium (Wako) with 10% fetal bovine serum (Biowest). Using FuGENE HD transfection reagent (Promega), 1 μg of pCAGGS or pCAGGS-Gcm1-Flag was introduced into 2.0 × 10 5 HEK293 cells in 12-well plates according to the protocol. To monitor the proliferation ability, the cells were incubated with 10 μM EdU for 6 h before cell harvest at 24 h and 48 h. After incubation, the cells were washed with PBS and fixed with 4% paraformaldehyde for 15 minutes at room temperature, and then washed again with PBS. The EdU assay was performed using Click-iT ® EdU Imaging Kits (Invitrogen) according to the manufacturer's instructions. Cells were stained with DAPI (Sigma). EdU-positive cells were counted separately in 10 randomly selected non-overlapping fields (400× magnification) in cells transfected with empty vector plasmid DNA and vector plasmid DNA containing Gcm1. The results were expressed as the percentage of EdU-positive cells. For inhibition of the TGF-β1 signaling assay, LY-364947 (Sigma) was used at a final concentration of 45 or 90 nM. After 48 h, the cultured cells were washed with PBS twice, and total RNAs were extracted by TRIzol (Thermo Fisher Scientific). Then, 1 μg of total RNA from cells was reacted with DNaseI (Roche) to digest genome DNA. Total RNAs were reverse-transcribed by prime script II (TakaRa) to prepare cDNA for real-time PCR. Real-time PCR was performed using the Roter-Gene SYBR Green PCR Kit (Qiagen). The PCR reaction involved 40 cycles, and the conditions were 95 °C for 5 s and 60 °C for 10 s. The specific primer sequences used are mentioned in Supplementary Table S2 . For immunostaining, cells were washed with PBS, fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, and subsequently incubated with the blocking solution for 60 min. Cells were immunostained with a primary antibody (anti-FLAG; F1804, Sigma-Aldrich, St. Louis, MO, USA) in the blocking solution for 1 h at room temperature, and subsequently incubated with the secondary antibody solution for 30 min at room temperature. Cells transfected with empty vector plasmid DNA were used as controls.
Ultrasensitive RNA in situ hybridization assay. Ultrasensitive RNA in situ hybridization was performed using fixed frozen tissue sections and the RNAscope 2.5 HD Duplex Detection Kit (ACDBio #322436). We used samples of control and Gcm1 cKO mice kidney at day 0 and day 3 after IRI. We followed the manufacturer's
